CompoAtlas

OZONOL®Ointment

Natural health product licensed in Canada

Licence holder
Exzell Pharma Inc.
NPN or DIN-HM
02152819
Status
Active licence
Licence date
27 March 2008
Revision date
28 November 2017
Form
Onguent
Route of administration
Topique
Application type
DIN de transition

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
phénol0.18 %
Oxyde de zinc3.72 %

Non-medicinal ingredients

Ichthammol, Petrolatum, Yellow, Camphre, Origanum Vulgare Oil, Aluminum potassium sulfate, Cire d'abeille jaune, Mineral oil, Thymol, Lanoline, Bicarbonate de sodium

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 2 yearsNot specifiedminimum: 3 Tous les jours ; maximum: 4 Tous les jours
AdultesNot specifiedNot specifiedminimum: 3 Tous les jours ; maximum: 4 Tous les jours

Uses authorised in Canada

For scrapes, minor burns & skin irritations, insect bites, chafing, chapping.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 02152819

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line